Collectively, it has been indicated that GATA3 is a major driver of epigenomic reprogramming that can directly influence the activity of oncogenes, suggesting a critical pathway through which inherited genetic variations might impact the risk of cancer [41]. Here, GATA3 is linked to cancer.